Dangerous deception--hiding the evidence of adverse drug effects.
Avorn
Jerry
J
Harvard Medical School and Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital, Boston, USA.
D000933:Antifibrinolytic Agents / Q000009:adverse effects*; D007611:Aprotinin / Q000009:adverse effects*; D008192:Deception; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans; D019370:Observation; D017594:Publication Bias; D012107:Research Design
D000933:Antifibrinolytic Agents; D007611:Aprotinin